IND filing of tivoxavir marboxil represents final step for formal consideration by the Center for the Biomedical Advanced ...
IND filing of tivoxavir marboxil represents final step for formal consideration by the Center for the Biomedical Advanced ...
Travere Therapeutics, Inc., (Nasdaq: TVTX) announced that today the U.S. Food and Drug Administration (FDA) has extended the review timeline of its supplemental New Drug Application (sNDA) for ...
Laboratories are no longer peripheral. They are central to modern clinical development - enabling earlier decision-making, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback